About Us

Procaps Group, S.A. ("Procaps Group") (NASDAQ: PROC) is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5.000 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over the counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions.

ESG Report 2022

Our Sustainable Way: Driving Innovation, shaping a Healthier Future

View Report
ESG Report

Recent News

Procaps Issues Shareholder Letter Update

October 10, 2024


Dear Shareholders,

As we navigate recent challenges at Procaps, I want to personally reaffirm our dedication to transparency, compliance, and sustainable management. We are committed to addressing the findings from our ongoing investigation with the utmost integrity for Procaps to emerge as a stronger, more resilient company and have developed a remediation plan to ensure we achieve that goal.

View More

Pharmaceutical Group dedicated to delivering health and nutrition

Pharmaceutical Group
dedicated to delivering
health and nutrition

We employ over 5.000 people across 13 countries

We employ over 5.000 people across 13 countries
 

Our products reach 50+ markets

Our products reach 
50+ markets